Cerebrospinal fluid NPTX2/p-tau ratio as a biomarker for cognitive decline in neurodegenerative diseases. - Gomes BF; Sauer M; Montoliu-Gaya L; Franquesa-Mullerat M; Bejanin A; Alcolea D; Lleó A; Illán-Gala I; Fortea J; Blennow K; Zetterberg H; Nilsson J; et al. (Alzheimer's & dementia (Amsterdam, Netherlands), 2026)